Buscar
Haleon PLC
HLNAñadir a la lista de seguimiento
10.168USD
0.0000.00%
Cierre 07-27 16:00（ET）Cotizaciones retrasadas 15 min
43.33BCap. mercado
36.91P/E TTM
Más Datos de Haleon PLC Compañía
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Información de Haleon PLC
Símbolo de cotizaciónHLN
Nombre de la empresaHaleon PLC
Fecha de salida a bolsaJul 18, 2022
Director ejecutivoMcnamara (Brian)
Número de empleados- -
Tipo de seguridadDepository Receipt
Fin del año fiscalJul 18
DirecciónBuilding 5, First Floor
CiudadWEYBRIDGE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited Kingdom
Código postalKT13 0NY
Teléfono441932822000
Sitio Webhttps://www.haleon.com/
Símbolo de cotizaciónHLN
Fecha de salida a bolsaJul 18, 2022
Director ejecutivoMcnamara (Brian)
Ejecutivos de Haleon PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Haleon PLC?
Los cinco principales accionistas de Haleon PLC son: Ms. Lisa Paley
¿Cuántas instituciones poseen acciones de Haleon PLC (HLN)?
A fecha de 2026Q1, 1090 instituciones poseen acciones de Haleon PLC, con un valor de mercado combinado de aproximadamente 575.83M, lo que representa el 12.97% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 12046665.00.
¿Cuál es la mayor fuente de ganancias de Haleon PLC?
El 2026Q1, el segmento empresarial Oral health generó la ganancia más alta para Haleon PLC, ascendiendo a 3.46B y representando el 31.38% de la ganancia total.